Apr 22, 2013
821:798
For every 798 shares held, investors received 821. The price per share adjusted from $792.00 to $769.81.
The split itself did not change the total investment value.
Clal Biotechnology Industries Ltd (TASE:CBI) operates in the Financial conglomerates industry.
Clal Biotechnology Industries Ltd company overviewClal Biotechnology Industries Ltd's most recent stock split was on April 22, 2013. It was a 821-for-798 forward split, so shareholders received 821 shares for every 798 they held.
Clal Biotechnology Industries Ltd has split its stock once. This history records one forward split, on April 22, 2013.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Clal Biotechnology Industries Ltd's 821-for-798 split on April 22, 2013, every 798 shares became 821 shares.
Clal Biotechnology Industries Ltd has not announced a new split in our records. Its most recent split was on April 22, 2013, 13 years ago. Companies announce splits in advance, and any new TASE:CBI split will appear on this page.
Already premium?